PRGO Q1 2021 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q1 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.0B-6.8% YoY

Gross Profit

$368M36.5% margin

Operating Income

$51M5.1% margin

Net Income

$38M3.8% margin

EPS (Diluted)

$0.28

QoQ Revenue Growth

-21.7%

Cash Flow

Operating Cash Flow

$200,000

Free Cash Flow

-$45M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$11.3B

Total Liabilities

$5.8B

Stockholders' Equity

$5.6B

Cash & Equivalents

$471M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.0B	$1.1B	-6.8%
Gross Profit	$368M	$394M	-6.4%
Operating Income	$51M	$86M	-40.5%
Net Income	$38M	$106M	-64.2%

Revenue Segments

Consumer Self-Care Americas

$641M63%

Consumer Self-Care International

$370M37%

Geographic Segments

UNITED STATES

$611M60%

Europe

$355M35%

Other Geographical Areas

$43M4%

IRELAND

$5M0%